Articles On Invitrocue (ASX:IVQ)

Life sciences firm Invitrocue Limited (IVQ) has entered a binding agreement to launch into the Brazillian and Latin American market Invitrocue’s Singaporean subsidiary will team up with South American businessman Felipe Eduardo de Almeida...

Yesterday, Stockhead reviewed the small caps that are devising treatments to fight cancer. There are also a handful of small caps that are seeking to help with diagnostics. In other words these small caps are either seeking to identify the...

Spies defecting, a foreign power secretly taking control of Australia via 5G, the stealthy infiltration of universities and CSIRO, a new arms race waged through cyber-warfare. This is not a John Le Carre novel, these are the headlines shapi...

There’s no shortage of ASX small caps trying to fight cancer. The number of people living with cancer continues to grow around the world. The World Health Organisation predicts next year there will be 4.5 million new cancer cases and 6.7 mi...

Viagra mouth spray maker SUDA Pharmaceuticals (ASX:SUD) has talked a multi-billion dollar pharmaceutical company into backing its tech. Sanofi-Aventis has signed a feasibility agreement to test the mouth spray technology with one of its own...

  Invitrocue Limited (ASX: IVQ) has announced that it has entered into a subscription agreement with ChinaLink Limited of up to US$10 million in 2 tranches and has formed a JV with the investors (ChinaLink Limited). ChinaLink is a Hong Kong...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...